Archives: “Systemic Diseases”

Assessment of damage in Takayasu’s arteritis

https://www.coltonconsortium.org/publications/assessment-of-damage-in-takayasus-arteritis/

Association of autoantibody concentrations and trajectories with lupus nephritis histologic features and treatment response

https://www.coltonconsortium.org/publications/association-of-autoantibody-concentrations-and-trajectories-with-lupus-nephritis-histologic-features-and-treatment-response/

Associations between blood DNA methylation and histopathologic features in lupus nephritis

https://www.coltonconsortium.org/publications/associations-between-blood-dna-methylation-and-histopathologic-features-in-lupus-nephritis/

Blood immunophenotyping identifies distinct kidney histopathology and outcomes in patients with lupus nephritis

https://www.coltonconsortium.org/publications/blood-immunophenotyping-identifies-distinct-kidney-histopathology-and-outcomes-in-patients-with-lupus-nephritis/

Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cells

https://www.coltonconsortium.org/publications/chimeric-antigen-receptor-t-cells-against-the-ighv4-34-b-cell-receptor-specifically-eliminate-neoplastic-and-autoimmune-b-cells/

Clinical and ultrasound features of a cohort of psoriasis patients without musculoskeletal symptoms: a prospective and multicenter study

https://www.coltonconsortium.org/publications/clinical-and-ultrasound-features-of-a-cohort-of-psoriasis-patients-without-musculoskeletal-symptoms-a-prospective-and-multicenter-study/

Clinical characteristics and outcomes of polyarteritis nodosa: an international study

https://www.coltonconsortium.org/publications/clinical-characteristics-and-outcomes-of-polyarteritis-nodosa-an-international-study/

Comparison of EULAR/PRINTO/PReS Ankara 2008 and 2022 ACR/EULAR classification criteria for granulomatosis with polyangiitis in children

https://www.coltonconsortium.org/publications/comparison-of-eular-printo-pres-ankara-2008-and-2022-acr-eular-classification-criteria-for-granulomatosis-with-polyangiitis-in-children/

A phase 3 trial of upadacitinib for giant-cell arteritis

https://www.coltonconsortium.org/publications/a-phase-3-trial-of-upadacitinib-for-giant-cell-arteritis/

A randomized, double-blind, placebo-controlled trial of abatacept for the treatment of relapsing, non-severe granulomatosis with polyangiitis

https://www.coltonconsortium.org/publications/a-randomized-double-blind-placebo-controlled-trial-of-abatacept-for-the-treatment-of-relapsing-non-severe-granulomatosis-with-polyangiitis/